Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2011

View Archived Issues

Aliskiren/amlodipine combination shows promise as initial therapy for hypertension

Phase II data presented on sorafenib in GIST and esophageal/gastroesophageal junction cancer

Polypill reduces cardiovascular risk factors in clinical trial

Pfizer develops novel inhibitors of HCV replication

Novel beta-secretase 1 inhibitors claimed at Lilly

Neuropilin-2 promotes epithelial-mesenchymal transition in CRC

CFAK-C4 receives FDA orphan drug status in pancreatic cancer based on preclinical data

First-line TH-302 plus gemcitabine shows promise in advanced/metastatic pancreatic cancer

Receptos begins treatment in phase I trial of RPC-1063 for multiple sclerosis

ALS Biopharma receives ADDF grant to develop HSP70 inducers for AD

Apogenix provides update on phase II APG-101 trial in glioblastoma multiforme

New agents with antidepressant activity claimed by Green Cross

Primary efficacy endpoint met in phase III Gattex trial in short bowel syndrome

DigiFab approved in Canada to treat digoxin toxicity/overdose

New lysophospholipid S1P1 receptor agonists patented

Allergan and MAP Pharma collaborate on Levadex for acute migraine

Vivalis divulges new inhibitors of RNA-directed RNA polymerase

Provectus completes treatment in phase I trial of PV-10 in liver cancer

Nuedexta launched in U.S. for treatment of pseudobulbar affect

Phase I data reported on NRM-8499, a prodrug for Alzheimer's disease

Peregrine fully enrolls phase Ib trial of bavituximab in HIV/HCV coinfection

CHMP recommends approval of BF-200 ALA for actinic keratosis

Onyx initiates rolling NDA for carfilzomib in multiple myeloma

Manhattan Pharma to advance AST-915 to phase II in essential tremor

Phase III trial of Cytotect for prevention of congenital CMV infection to continue

Faron and Maruishi to collaborate on Traumakine program in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...